PAVmed (PAVM) Other Non-Current Liabilities (2017 - 2025)

PAVmed's Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $6.9 million for Q3 2025.

• On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $6.9 million in Q3 2025; TTM through Sep 2025 was $6.9 million, a N/A change from a year earlier, with the FY2024 full-year figure at $29.1 million, down 34.16% from the prior year.
• Other Non-Current Liabilities improved to $6.9 million in Q3 2025 per PAVM's latest filing, from $6.8 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $45.5 million in Q1 2024 and bottomed at $291000.0 in Q3 2023.
• The 4-year median for Other Non-Current Liabilities is $31.6 million (2022), against an average of $26.8 million.
• Biggest YoY gain for Other Non-Current Liabilities was 804.08% in 2023; the steepest drop was 99.18% in 2023.
• Year by year, Other Non-Current Liabilities stood at $33.6 million in 2022, then surged by 31.35% to $44.2 million in 2023, then plunged by 34.16% to $29.1 million in 2024, then plunged by 76.29% to $6.9 million in 2025.
• Per Business Quant, the three latest PAVM Other Non-Current Liabilities figures stand at $6.9 million (Q3 2025), $6.8 million (Q2 2025), and $6.6 million (Q1 2025).